Skip to main content
Erschienen in: Journal of Neurology 12/2020

Open Access 31.10.2019 | Pioneers in Neurology

Izydor Fajersztajn-Krzemicki (1867–1935)

verfasst von: Sławomir Gonkowski, Jaroslaw Calka

Erschienen in: Journal of Neurology | Ausgabe 12/2020

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN
Izydor Fajersztajn-Krzemicki (Fig. 1) was born in a Jewish family on September 25, 1867, in Warsaw, which at that time was a part of the Russian Empire [1]. In 1886, he passed the secondary-school-leaving exam in his hometown [2] and started to study medicine at Warsaw University, receiving his medical degree in 1891 [1]. Soon afterwards he went to Cracow, which at that time was located within the borders of the Austro-Hungarian Empire. In Cracow, Fajersztajn-Krzemicki continued his studies at the Jagiellonian University, where in 1893 he received a doctoral diploma in medical sciences [1, 3, 4].
In the same year, Izydor Fajersztajn-Krzemicki travelled around Europe and deepened his knowledge of medicine. He worked at the clinics directed by Richard von Krafft-Ebing in Vienna and Adolf von Strümpell in Erlangen [1]. In 1894, he went to Lvov, where he lived and worked for the rest of his life. Initially, he worked as an assistant surgeon at the Public Hospital [3].
In 1898, Fajersztajn-Krzemicki became the head of the Department of Nervous Illnesses at the Public Policlinic, and soon afterwards the director of all policlinics [4]. He held this function until 1934, when he resigned for health reasons. Moreover, from 1918 to his death, he was head of a sanatorium for patients with mental and neurological diseases [1, 3]. Izydor Fajersztajn-Krzemicki died on February 3 or 4, 1935, in Lvov [1, 5].
Fajersztajn-Krzemicki was not only a neurology practitioner, consummate clinician and diagnostician, but also an inquisitive scientist. The first experiments he conducted during his studies at Warsaw University [1], under the direction of the famous histologist Henryk Hoyer, studied innervation of the frog and obtained results published in 1889 in the Journal of Warsaw Medical Association [1].
However, Fajersztajn-Krzemicki has gone down in the history of neurology thanks to his later studies. He was a pioneer of the histopathology of the nervous system. In 1901, he was the first to describe the silver staining method of visualization of nerve fibers in an article in German entitled “Ein neues Silberimprägnationsverfahren als Mittel zur Färbung der Axencylinder” (A new silver impregnation process as a means of coloring the axons), which was published in the journal “Neurologisches Zentralblatt” [6]. Soon afterwards this method was slightly modified by the German neurologist Max Bielschowsky (1869–1940) [7] and the use of silver staining to visualise nerves is universally known as Bielschowsky stain [1].
Fajersztajn-Krzemicki was a modest person and he did not fight for the name of discoverer of this method. As mentioned by another Polish neurologist, Kazimierz Orzechowski, Fajersztajn-Krzemicki was content with the letter from the distinguished neuroscientist Ludwig Edinger (1855–1918) [8], written just after the publication of Bielchowsky’s modification [4], in which Edinger claimed that Fajersztajn-Krzemicki was the discoverer of this method [1, 4].
Fajersztajn-Krzemicki was one of the first scientists to use Röntgen radiation to photograph the structures located in the brain, as well as constructing (according to his invention) a macrotome to do cross sections of this organ [1, 3]. However, the surname of Fajersztajn-Krzemicki went into the pages of neurology textbooks due to his studies on reflexes during spinal cord injury. Namely, in 1901, he described for the first time the crossed symptom, also known as “well leg-raising test,” during sciatica [1]. This symptom is observed in unilateral sciatica when raising the healthy (“well”) leg causes the pain in the symptomatic (“sick”) leg, which is not raised. The pain is caused because raising the healthy leg causes tension in the nerve root not only on this side of the body but also along the midline of the cauda equina and in the contralateral nerve roots [9]. Fajerszatajn-Krzemicki described this observation in the article “Ueber das gekreuzte Ischiasphänomen. Ein Beitrag zur Symptomatologie der Ischias (About the crossed sciatica phenomenon. A contribution to the symptomatology of sciatica) published in journal “Wiener klinische Wochenschrift” [10]. At the present time, this symptom is sometimes called the “Fajersztajn test,” “Fajersztajn-Krzemicki test,” or the “well leg raising test of Fajersztajn” and is considered to be an upgraded form of Lasègue's sign [1, 3, 9].
In the 1930s, Izydor Fajersztajn-Krzemicki practised ophthalmology. He examined visual fields using an instrument called a “campimeter” and developed his own formula to study the blind spot [1]. Moreover, Fajersztajn-Krzemicki constructed an apparatus which he called an “equatorial pregometer,” enabling the detection of even minor disorders in the extraocular muscles [1].
Due to the achievements of Fajersztajn-Krzemicki, after his death, the Polish neurologist Jakub Rothfeld wrote “Polish neurology lost one of the bravest worker. Krzemicki was a comprehensive mind with a wide range of interests in the area of medicine, physics, biology and mathematics. As a scientist he was precise, critical and demanding, especially with himself” [3].

Compliance with ethical standards

Conflicts of interest

The authors state that there is no conflict of interest.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://​creativecommons.​org/​licenses/​by/​4.​0/​), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
download
DOWNLOAD
print
DRUCKEN

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Neuer Inhalt

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
1.
Zurück zum Zitat Herman E (1958) Polish neurologists (book in Polish). Państwowy Zakład Wydawnictw Lekarskich, Warsaw Herman E (1958) Polish neurologists (book in Polish). Państwowy Zakład Wydawnictw Lekarskich, Warsaw
2.
Zurück zum Zitat Anon (1886) Exams of maturiti (article in Polish). Patenty Kurjer Codzienny 176:3 Anon (1886) Exams of maturiti (article in Polish). Patenty Kurjer Codzienny 176:3
3.
Zurück zum Zitat Rothfeld J (1935) Dr Izydor Krzemicki (article in Polish). Polska Gazeta Lekarska 14:151 Rothfeld J (1935) Dr Izydor Krzemicki (article in Polish). Polska Gazeta Lekarska 14:151
4.
Zurück zum Zitat Orzechowski K (1935) Izydor (Fajersztajn) Krzemicki (article in Polish). Neurologia Polska 18:383–386 Orzechowski K (1935) Izydor (Fajersztajn) Krzemicki (article in Polish). Neurologia Polska 18:383–386
5.
Zurück zum Zitat Anon (1935) From the funeral card (article in Polish). Gazeta Lwowska 28:3 Anon (1935) From the funeral card (article in Polish). Gazeta Lwowska 28:3
6.
Zurück zum Zitat Fajersztajn I (1901) A new silver impregnation process as a means of coloring the axons (article in German). Neurologisches Zentralblatt 20:98–106 Fajersztajn I (1901) A new silver impregnation process as a means of coloring the axons (article in German). Neurologisches Zentralblatt 20:98–106
7.
Zurück zum Zitat Stahnisch FW (2015) Max Bielschowsky (1869–1940). J Neurol 262:792–794CrossRef Stahnisch FW (2015) Max Bielschowsky (1869–1940). J Neurol 262:792–794CrossRef
8.
Zurück zum Zitat Stahnisch FW (2008) Ludwig Edinger (1855–1918). J Neurol 255:147–148CrossRef Stahnisch FW (2008) Ludwig Edinger (1855–1918). J Neurol 255:147–148CrossRef
9.
Zurück zum Zitat McGill S (2007) Low beck disorders Evidence—based prevention and rehabilitation, 2nd edn. Human Kinetics, Champaign McGill S (2007) Low beck disorders Evidence—based prevention and rehabilitation, 2nd edn. Human Kinetics, Champaign
10.
Zurück zum Zitat Fajersztajn I (1901) About the crossed sciatica phenomenon. A contribution to the symptomatology of sciatica (article in German). Wien Klin Wochenschr 14:41–47 Fajersztajn I (1901) About the crossed sciatica phenomenon. A contribution to the symptomatology of sciatica (article in German). Wien Klin Wochenschr 14:41–47
Metadaten
Titel
Izydor Fajersztajn-Krzemicki (1867–1935)
verfasst von
Sławomir Gonkowski
Jaroslaw Calka
Publikationsdatum
31.10.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 12/2020
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-019-09606-4

Weitere Artikel der Ausgabe 12/2020

Journal of Neurology 12/2020 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.